Abstracts Archive - Page 1970 of 2605 - ACR Meeting Abstracts

Abstract Number: 1510 • 2015 ACR/ARHP Annual Meeting
The Association Between HDL Cholesterol Efflux Capacity, Citrullinated ApoA1 and Anti-Citrullinated ApoA1 Antibodies in Rheumatoid Arthritis
Katherine Liao¹, Jing Cui¹, Christopher Rhodes², Lauren J. Lahey², Martin Playford³, I-Hsin Kuo¹, Michelle Frits¹, Christine Iannaccone¹, Jonathan S. Coblyn⁴, Michael Weinblatt¹, Nancy Shadick⁵, Nehal N. Mehta³ and Jeremy Sokolove², ¹Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, ²Medicine, VA Palo Alto HealthCare System and Stanford University, Palo Alto, CA, ³NHLBI, National Institutes of Health, Bethesda, MD, ⁴Brigham & Women's Hospital, Boston, MA, ⁵Division of Rheumatology, Immunology & Allergy, Brigham & Women's Hospital, Boston, MA
Background/Purpose: High density lipoprotein (HDL) cholesterol efflux capacity measures how well HDL particles remove cholesterol from lipid-laden macrophages, such as those found in atherosclerotic plaques. …
Abstract Number: 1511 • 2015 ACR/ARHP Annual Meeting
Increased Prevalence of Anti-Nuclear and Anti-SSA Autoantibodies in African American Rheumatoid Arthritis Patients Versus Matched Caucasian Rheumatoid Arthritis Patients
Tyler Sevco¹, Douglas P. Landsittel², Chengli Shen³, Bruce Rabin⁴ and Larry W. Moreland⁵, ¹Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, ²Medicine, University of Pittsburgh, Pittsburgh, PA, ³University of Pittsburgh School of Medicine, Pittsburgh, PA, ⁴Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, ⁵Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: African American (AA) patients with rheumatoid arthritis (RA) have worse Health Assessment Questionnaire (HAQ) scores and increased disease activity clinically compared to Caucasian (CAU)…
Abstract Number: 1512 • 2015 ACR/ARHP Annual Meeting
Incidence of Co-Morbid Autoimmune Diseases in Patients with Rheumatoid Arthritis
TA Simon¹, H Kawabata¹, JM Esdaile², V Moorthy³ and S Suissa⁴, ¹Bristol-Myers Squibb, Hopewell, NJ, ²Arthritis Research Canada, Vancouver, BC, Canada, ³Mu Sigma, Northbrook, IL, ⁴McGill University, Montreal, QC, Canada
Background/Purpose: Rheumatoid arthritis (RA) is one of more than 80 different types of autoimmune diseases, many of which, including RA, share common pathogenic mechanisms, resulting…
Abstract Number: 1513 • 2015 ACR/ARHP Annual Meeting
Reactivation of Hepatitis B-Infection in German Patients with Inflammatory Rheumatic Diseases Treated with Biologics – a Monocentric Analysis Involving 1107 Patients
Eva Christina Scharbatke¹, Sonja Kreissl-Kemmer², Hans-Peter Tony³, Marc Schmalzing⁴ and Andreas Geier², ¹Rheumatology/Immunology, University hospital Wuerzburg, Wuerzburg, Germany, ²Hepatology, University hospital Wuerzburg, Wuerzburg, Germany, ³University Hospital Würzburg, Würzburg, Germany, ⁴Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, Germany
Background/Purpose: Hepatitis B virus (HBV) reactivation is a common complication of immunosuppressive treatment in countries with a high prevalence of HBV infection. Biologics – and…
Abstract Number: 1514 • 2015 ACR/ARHP Annual Meeting
Incidence and Risk Factors of Malignancy in a Cohort of Rheumatoid Arthritis Patients from Singapore
XR Lim¹, LZ Liu², X Gao², J W L Tan¹, L W Koh³, TY Lian¹, W Q See⁴, KP Leong¹, ET Koh¹ and TTSH RA Study Group, ¹Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore, ²Clinical Research and Innovation Office, Tan Tock Seng Hospital, Singapore, Singapore, ³Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore, ⁴Tan Tock Seng Hospital, singapore, Singapore
Background/Purpose: Patients with rheumatoid arthritis (RA) have been shown to have an increased risk of developing malignancies. This study was undertaken to determine the incidence…
Abstract Number: 1515 • 2015 ACR/ARHP Annual Meeting
Accounting for Rheumatoid Arthritis in the Determination of 10 Year Cardiovascular Risk
Rupal Chavda and Rochella A. Ostrowski, Rheumatology, Loyola University Medical Center, Maywood, IL
Background/Purpose: Patients with rheumatoid arthritis (RA) carry a higher risk for cardiovascular disease (CVD) independent of traditional risk factors. In this study, we set out…
Abstract Number: 1516 • 2015 ACR/ARHP Annual Meeting
Quality Improvement in Elderly Patients with Rheumatoid Arthritis: Pharmacotherapy and Identification of Cognitive Dysfunction
Brett Smith¹ and Kenneth S. O'Rourke², ¹Section on Rheumatology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC, ²Section on Rheumatology and Immunology, Wake Forest University School of Medicine, Winston-Salem, NC
Background/Purpose: Cognitive impairment (CI) casts a significant burden on individuals, caretakers and the US health care system with an estimated prevalence between 10-20%. While CI…
Abstract Number: 1518 • 2015 ACR/ARHP Annual Meeting
Relationship Between Estimated Sodium and Potassium Intake with Blood Pressure and Inflammatory Markers in Patients with Rheumatoid Arthritis
Cecilia P. Chung¹, Michelle J. Ormseth², Annette M. Oeser³, Joseph F. Solus⁴, Chimalum Okafor⁵, Jens Titze⁵, Yahua Zhang⁵ and C. Michael Stein⁶, ¹Medicine, Div of Rheumatology & Immunology, Vanderbilt University, Nashville, TN, ²Department of Medicine, Division of Rheumatology, Vanderbilt University, Nashville, TN, ³Vanderbilt University, Nashville, TN, ⁴Clinical Pharmacology, Vanderbilt University, Nashville, TN, ⁵Medicine, Vanderbilt University, Nashville, TN, ⁶Div of Clinical Pharmacology, Vanderbilt University, Nashville, TN
Background/Purpose: Hypertension is highly prevalent in patients with rheumatoid arthritis (RA). High sodium and low potassium intake are both modifiable determinants of blood pressure in…
Abstract Number: 1519 • 2015 ACR/ARHP Annual Meeting
Pleuropulmonary Manifestations in Rheumatoid Arthritis Patients
Suzan Attar¹ and Omar Amoudi², ¹Internal Medicine, MBBCH. FRCPC. ABIM, Jeddah, Saudi Arabia, ²Internal Medicine, FRCPC, Jeddah, Saudi Arabia
Background/Purpose: Pulmonary involvement in rheumatoid arthritis (RA) patients is associated with high morbidity and mortality. Nevertheless, limited data are available regarding such lung complications in…
Abstract Number: 1520 • 2015 ACR/ARHP Annual Meeting
Safety, Clinical and Immunologic Effectiveness of the Live Zoster Vaccine Administered to Patients Receiving Anti-TNF Biologics
Jeffrey R. Curtis^1,2, Anita Turner³, Corretta Thomas⁴, Stacey Cofield⁴, Randall Parks⁵, Jennifer H. Ku⁶, Ilhem Messaoudi- Powers⁷, Keith Wanzeck¹ and Kevin L. Winthrop⁸, ¹University of Alabama at Birmingham, Birmingham, AL, ²Rheumatology & Immunology, University of Alabama-Birmingham, Birmingham, AL, ³Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁴School of Public Health, University of Alabama at Birmingham, Birmingham, AL, ⁵Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁶Casey Eye Institute, Oregon Health & Science Univ, Portland, OR, ⁷Oregon Health and Sciences University, Portland, OR, ⁸Oregon Health & Science University, Portland, OR
Background/Purpose: The live herpes zoster vaccine (ZV) has been shown to be safe and effective in large randomized controlled trials of older adults. It is…
Abstract Number: 1521 • 2015 ACR/ARHP Annual Meeting
Screening for Urinary Tract Infection in Rheumatoid Arthritis Patients Treated with TNF-Inhibitors in the Daily Clinic
Renata Baronaite Hansen¹, Anne Brun Hesselvig², Rolf Magnus Arpi², Eva Kristin Jonassen¹, Gunhild Bukh¹ and Ole Rintek Madsen¹, ¹Department of Rheumatology/C, Department of Rheumatology/C, Copenhagen University Hospital Gentofte, Hellerup, Denmark, ²Department of Clinical Microbiology, Department of Clinical Microbiology, Copenhagen University Hospital Herlev, Herlev, Denmark
Background/Purpose: Patients with rheumatoid arthritis (RA) treated with biologic agents are at increased risk of infection. Therefore, screening for urinary tract infection (UTI) with urine…
Abstract Number: 1522 • 2015 ACR/ARHP Annual Meeting
Correlation of Oxidized Low Density Lipoprotein Levels with Carotid Intima Media Thickness in Rheumatoid Arthritis Patients
GHAN SHYAM PANGTEY¹, SANJAY PARMAR¹, RITU SINGH² and RAMA ANAND³, ¹DEPARTMENT OF MEDICINE, LADY HARDINGE MEDICAL COLLEGE, New Delhi, India, ²BIOCHEMISTRY, LADY HARDINGE MEDICAL COLLEGE, New Delhi, India, ³DEAPRTMENT OF RADIOLOGY, LADY HARDINGE MEDICAL COLLEGE, DELHI, India
Background/Purpose: Rheumatoid Arthritis (RA) patients are more prone to atherosclerosis. Oxidation of Low-density lipoprotein (LDL) is an important event in the development of atherosclerosis, especially…
Abstract Number: 1523 • 2015 ACR/ARHP Annual Meeting
Ischemia Modified Albumin Levels in Rheumatoid Arthritis
Ali Ugur Uslu¹, Adem Kucuk², Sevket Balta³, Sevket Arslan⁴, Levent Tekin⁵, Sami Kucuksen⁶, Aysun Toker⁷ and Mehmet Kayrak⁸, ¹Internal Medicine, Eskisehir Military Hospital, Eskisehir, Turkey, ²Necmettin Erbakan U Meram T F, Necmettin Erbakan U Meram T F, Konya, Turkey, ³Cardiology, Eskisehir Military Hospital, Eskisehir, Turkey, ⁴Allergy and Clinical Immunology, Necmettin Erbakan University, Konya, Turkey, ⁵Physical Medicine and Rehabilitation, Beyhekim State Hospital, Konya, Turkey, ⁶MD, kONYA, Turkey, ⁷Biochemistry, Necmettin Erbakan University, Konya, Turkey, ⁸Necmettin Erbakan University, Division of Cardiology, Konya, Turkey
Background/Purpose: Cardiovascular diseases, among which atherosclerotic heart disease, are known to be one of the most important mortality and morbidity causes in patients with Rheumatoid…
Abstract Number: 1524 • 2015 ACR/ARHP Annual Meeting
Evaluation of Changes in Cardiovascular Risk Factors Among Patients with RA Prescribed Biologic Dmards
E Alemao¹, T Simon², KK Gandhi¹, H Kawabata² and Jeffrey R. Curtis³, ¹Bristol-Myers Squibb, Princeton, NJ, ²Bristol-Myers Squibb, Hopewell, NJ, ³University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Studies have reported that TNF-inhibitors (TNF-Is) are associated with a reduced risk of cardiovascular (CV) events,1 but data on their effects on traditional CV…
Abstract Number: 1525 • 2015 ACR/ARHP Annual Meeting
Detection of Previous Tuberculosis Infections in Japanese Rheumatoid Arthritis Patients: Comparison of Two Interferon-G Releasing Assays and the Impact of CD4-Positive Lymphocytes
Shogo Banno¹, Shiho Iwagaitsu², Taio Naniwa³, Hironobu Nobata⁴, Hirokazu Imai⁴, Shinya Tamechika², Shinji Maeda² and Akio Niimi², ¹Rheumatology and Nephrology, Aichi Medical University School of Medicine, Aichi-prefecture, Japan, ²Allergy, Respiratory Medicine and Immunology, Nagoya City University Graduate School of Medical Science, Nagoya City, Japan, ³Allergy, Respiratory Medicine and Immunology, Nagoya City University Graduate School of Medical Science, Nagoya city, Japan, ⁴Rheumatology and Nephrology, Aichi Medical University School of Medicine, Nagakute City, Japan
Background/Purpose: We aimed to evaluate the performance of QFT-GIT and T-SPOT.TB assays to predict the risk of latent tuberculosis infection (LTBI) in Japanese rheumatoid arthritis…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].